• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

CELLECTIS (ALCLS)

CELLECTIS
Sell: €1.38|Buy: €1.42|Change: 0.01 (0.43%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Address

8 rue de la Croix Jarry
Paris
FRA
75013

Website

https://www.cellectis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Cellectis SA Fourth Quarter Earnings Conference Call for 20252026-03-13T08:00:00
Cellectis SA Fourth Quarter Earnings Results for 20252026-03-13T00:00:00
Cellectis SA Annual Report for 20252026-03-13T00:00:00
Cellectis SA Third Quarter Earnings Conference Call for 20252025-11-05T08:00:00
Cellectis SA Third Quarter Earnings Results for 20252025-11-04T00:00:00
Cellectis SA Second Quarter Earnings Results for 20252025-08-06T00:00:00
Cellectis SA Annual General Meeting for 20242025-06-27T14:30:00
Cellectis SA First Quarter Earnings Conference Call for 20252025-05-29T08:00:00
Cellectis SA First Quarter Earnings Results for 20252025-05-28T00:00:00

Previous key dates

NameKey Date
Cellectis SA First Quarter Earnings Conference Call for 20252025-05-29T08:00:00
Cellectis SA First Quarter Earnings Results for 20252025-05-28T00:00:00
The 2nd CRISPR Medicine Conference 20252025-04-10T09:32:00
Cellectis SA Fourth Quarter Earnings Conference Call for 20242025-03-14T08:00:00
Cellectis SA Annual Report for 20242025-03-14T00:00:00
Cellectis SA Fourth Quarter Earnings Results for 20242025-03-13T00:00:00
Cellectis SA Third Quarter Earnings Conference Call for 20242024-11-05T08:00:00
Cellectis SA Third Quarter Earnings Results for 20242024-11-04T00:00:00
Cellectis SA Second Quarter Earnings Results for 20242024-08-06T00:00:00
Cellectis SA Annual General Meeting for 20232024-06-28T14:30:00
Cellectis SA First Quarter Earnings Conference Call for 20242024-05-29T08:00:00
Cellectis SA First Quarter Earnings Results for 20242024-05-28T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.